47338 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 28
16:46 UTC
|
AFRM
Affirm
|
◎ Target | Rayna Kumar ★★★☆☆ #1424 | Outperform | $100.00→ $104.00+4.0% |
|
Aug 28
15:46 UTC
|
WDAY
Workday
|
◎ Target | Rishi Jaluria ★★★★☆ #642 | Outperform | $220.00→ $240.00+9.1% |
|
Aug 28
15:46 UTC
|
WDAY
Workday
|
◎ Target | Raimo Lenschow ★★★★★ #278 | Overweight | $200.00→ $224.00+12.0% |
|
Aug 28
15:46 UTC
|
WDAY
Workday
|
◎ Target | Derrick Wood ★★★★★ #207 | Hold | $220.00→ $210.00-4.5% |
|
Aug 28
15:46 UTC
|
VEEV
Veeva Systems
|
◎ Target | Tyler Radke ★★★★★ #112 | Neutral | $190.00→ $273.00+43.7% |
|
Aug 28
15:46 UTC
|
ULTA
Ulta Beauty
|
◎ Target | Steven Zaccone ★★★★☆ #736 | Neutral | $560.00→ $580.00+3.6% |
|
Aug 28
15:46 UTC
|
ULTA
Ulta Beauty
|
◎ Target | Adrienne Yih ★★★☆☆ #1902 | Overweight | $647.00→ $645.00-0.3% |
|
Aug 28
15:46 UTC
|
STDN
Standard Nuclear
|
◎ Target | Christopher Dendrinos not yet tracked | Outperform | $11.00→ $13.00+18.2% |
|
Aug 28
15:46 UTC
|
SQM
Sociedad Quimica y Minera
|
◎ Target | Lucas Ferreira ★★★☆☆ #1281 | Neutral | $100.00→ $94.00-6.0% |
|
Aug 28
15:46 UTC
|
S
SentinelOne
|
◎ Target | Saket Kalia ★★★★★ #104 | Equal Weight | $22.00→ $23.00+4.5% |
|
Aug 28
15:46 UTC
|
S
SentinelOne
|
◎ Target | Hamza Fodderwala not yet tracked | Equal Weight | $17.00→ $23.00+35.3% |
|
Aug 28
15:46 UTC
|
S
SentinelOne
|
◎ Target | Rob Owens ★★★★★ #3 | Neutral | $15.00→ $20.00+33.3% |
|
Aug 28
15:46 UTC
|
S
SentinelOne
|
◎ Target | Fatima Boolani ★★★★★ #49 | Neutral | $17.00→ $23.00+35.3% |
|
Aug 28
15:46 UTC
|
RDNT
RadNet
|
◎ Target | Andrew Mok not yet tracked | Overweight | $65.00→ $79.00+21.5% |
|
Aug 28
15:46 UTC
|
RCEL
Avita Medical
|
◎ Target | Frank Takkinen ★★☆☆☆ #2796 | Buy | $8.00→ $12.00+50.0% |
|
Aug 28
15:46 UTC
|
RBRK
Rubrik
|
◎ Target | Saket Kalia ★★★★★ #104 | Overweight | $110.00→ $115.00+4.5% |
|
Aug 28
15:46 UTC
|
RBRK
Rubrik
|
◎ Target | James Fish ★★★★☆ #337 | Overweight | $91.00→ $114.00+25.3% |
|
Aug 28
15:46 UTC
|
PYPL
PayPal
|
◎ Target | Dominick Gabriele ★★★★☆ #640 | Hold | $62.00→ $50.00-19.4% |
|
Aug 28
15:46 UTC
|
PURR
Hyperliquid Strategies
|
◎ Target | James McIlree ★☆☆☆☆ #2992 | Buy | $9.75→ $17.00+74.4% |
|
Aug 28
15:46 UTC
|
P
Everpure
|
◎ Target | Nehal Chokshi ★★★☆☆ #1237 | Outperform | $90.00→ $128.00+42.2% |
|
Aug 28
15:46 UTC
|
P
Everpure
|
◎ Target | Tim Long ★★★☆☆ #1505 | Equal Weight | $84.00→ $110.00+31.0% |
|
Aug 28
15:46 UTC
|
NTNX
Nutanix
|
◎ Target | Tim Long ★★★☆☆ #1505 | Equal Weight | $53.00→ $75.00+41.5% |
|
Aug 28
15:46 UTC
|
MRVL
Marvell Technology
|
◎ Target | Joseph Moore ★★★☆☆ #1676 | Equal Weight | $224.00→ $246.00+9.8% |
|
Aug 28
15:46 UTC
|
MRVL
Marvell Technology
|
◎ Target | Joshua Buchalter ★★☆☆☆ #2334 | Hold | $225.00→ $245.00+8.9% |
|
Aug 28
15:46 UTC
|
MLM
Martin Marietta Materials
|
◎ Target | Anthony Codling ★★★☆☆ #1518 | Sec→ r Perform | $610.00→ $620.00+1.6% |
|
Aug 28
15:46 UTC
|
LMRI
Lumexa Imaging
|
◎ Target | Andrew Mok not yet tracked | Overweight | $9.00→ $13.00+44.4% |
|
Aug 28
15:46 UTC
|
LFVN
Lifevantage
|
◎ Target | Brooks O'Neil ★☆☆☆☆ #3022 | Hold | $5.00→ $6.00+20.0% |
|
Aug 28
15:46 UTC
|
HPQ
HP
|
◎ Target | Tim Long ★★★☆☆ #1505 | Underweight | $19.00→ $23.00+21.1% |
|
Aug 28
15:46 UTC
|
HEI
Heico
|
◎ Target | John Godyn ★★★☆☆ #1660 | Buy | $429.00→ $441.00+2.8% |
|
Aug 28
15:46 UTC
|
GAP
GAP
|
◎ Target | Alex Straton not yet tracked | Equal Weight | $21.00→ $23.00+9.5% |
|
Aug 28
15:46 UTC
|
GAP
GAP
|
◎ Target | Jonna Kim ★★★★☆ #480 | Buy | $23.00→ $27.00+17.4% |
|
Aug 28
15:46 UTC
|
GAP
GAP
|
◎ Target | Adrienne Yih ★★★☆☆ #1902 | Equal Weight | $20.00→ $23.00+15.0% |
|
Aug 28
15:46 UTC
|
ETN
Eaton
|
◎ Target | Chris Snyder not yet tracked | Overweight | $500.00→ $520.00+4.0% |
|
Aug 28
15:46 UTC
|
ESTC
Elastic
|
◎ Target | Rob Owens ★★★★★ #3 | Overweight | $85.00→ $130.00+52.9% |
|
Aug 28
15:46 UTC
|
ESTC
Elastic
|
◎ Target | Ittai Kidron ★★★★★ #107 | Outperform | $100.00→ $118.00+18.0% |
|
Aug 28
15:46 UTC
|
ESTC
Elastic
|
◎ Target | Brent Thill ★★★☆☆ #1113 | Buy | $100.00→ $120.00+20.0% |
|
Aug 28
15:46 UTC
|
ESTC
Elastic
|
◎ Target | Brian Essex ★★★★☆ #679 | Overweight | $93.00→ $105.00+12.9% |
|
Aug 28
15:46 UTC
|
DLTR
Dollar Tree
|
◎ Target | Simeon Gutman ★★★★☆ #827 | Equal Weight | $130.00→ $145.00+11.5% |
|
Aug 28
15:46 UTC
|
DG
Dollar General
|
◎ Target | Simeon Gutman ★★★★☆ #827 | Equal Weight | $132.00→ $145.00+9.8% |
|
Aug 28
15:46 UTC
|
DG
Dollar General
|
◎ Target | Peter Keith ★★★☆☆ #1145 | Neutral | $118.00→ $123.00+4.2% |
|
Aug 28
15:46 UTC
|
BIDU
Baidu
|
◎ Target | Shyam Patil ★★★★☆ #889 | Neutral | $140.00→ $105.00-25.0% |
|
Aug 28
15:46 UTC
|
BBY
Best Buy
|
◎ Target | Seth Sigman ★★★☆☆ #1695 | Buy | $77.00→ $85.00+10.4% |
|
Aug 28
15:46 UTC
|
BBY
Best Buy
|
◎ Target | Simeon Gutman ★★★★☆ #827 | Equal Weight | $80.00→ $90.00+12.5% |
|
Aug 28
15:46 UTC
|
BABA
Alibaba Group
|
◎ Target | Shyam Patil ★★★★☆ #889 | Positive | $185.00→ $190.00+2.7% |
|
Aug 28
15:46 UTC
|
AVAH
Aveanna Healthcare
|
◎ Target | Andrew Mok not yet tracked | Overweight | $9.50→ $15.00+57.9% |
|
Aug 28
15:46 UTC
|
AFRM
Affirm
|
◎ Target | James Friedman ★★★☆☆ #1401 | Positive | $105.00→ $110.00+4.8% |
|
Aug 28
15:46 UTC
|
AFRM
Affirm
|
◎ Target | Bill Carcache not yet tracked | Overweight | $103.00→ $115.00+11.7% |
|
Aug 28
15:46 UTC
|
AFRM
Affirm
|
◎ Target | Connor Allen not yet tracked | Overweight | $90.00→ $105.00+16.7% |
|
Aug 28
15:46 UTC
|
AFRM
Affirm
|
◎ Target | Nik Cremo ★★★☆☆ #1626 | Overweight | $97.00→ $105.00+8.2% |
|
Aug 28
15:46 UTC
|
MRNA
Moderna
|
↑ Upgrade | firm only | Outperform |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.